New York Medicaid: Updated MAT formulary effective as of March 22, 2022
Updated MAT formulary now in effect
As of March 22, 2022, an updated single statewide medication assisted treatment (MAT) formulary is in effect. In accordance with Social Services Law Title 11, Section 364-j (26) (b), managed care providers shall not require prior authorization for any buprenorphine products, methadone or long-acting injectable naltrexone for detoxification or maintenance treatment of a substance use disorder prescribed according to generally accepted national professional guidelines for the treatment of a substance use disorder.
Single statewide MAT formulary effective March 22, 2022 Please take note of the updated MAT formulary as outlined below.